Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Rezolute, Inc. (RZLT) Cash Flow Statement

Rezolute, Inc. (RZLT) generated -$64.6M of operating cash flow over the twelve months to 2026-06-30, spent $0 on capital expenditure and had free cash flow of -$64.6M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RZLTRezolute, Inc.Follow RZLT — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
372.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2012
Jun 12
FY2013
Jun 13
FY2014
Jun 14
FY2015
Jun 15
FY2016
Jun 16
FY2017
Jun 17
FY2018
Jun 18
FY2019
Jun 19
FY2020
Jun 20
FY2021
Jun 21
FY2022
Jun 22
FY2023
Jun 23
FY2024
Jun 24
FY2025
Jun 25
FY2026
Jun 26
TTM
Jun 26
Trend
Operating cash flow-0.0-1.6-3.2-7.1-10.5-13.3-14.1-15.3-24.2-20.4-39.6-44.5-57.4-69.1-64.6-64.6
Capital expenditure———————0.00.0——0.2——0.0-0.0
Free cash flow———————-15.4-24.2——-44.6——-64.6-64.6
Share repurchases————————————0.0———
Stock-based compensation—3.71.12.83.86.05.12.63.34.03.77.37.47.114.5—

USD millions · SEC XBRL

Rezolute, Inc. — questions

What is Rezolute, Inc.'s operating cash flow?
-$64.6M over the twelve months to 2026-06-30.
How much does Rezolute, Inc. spend on capital expenditure?
$0 over the twelve months to 2026-06-30.
What is Rezolute, Inc.'s free cash flow?
-$64.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Rezolute, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.